We are live on ! Find out more
PVH

Psagot Value Holdings Portfolio holdings

AUM $11M
1-Year Est. Return 32.09%
This Fund
S&P 500
This Quarter Est. Return
+13.15%
1 Year Est. Return
+32.09%
3 Year Est. Return
+45.93%
5 Year Est. Return
+142.05%
10 Year Est. Return
+219.25%
AUM
$240M
AUM Growth
-$98.9M
Cap. Flow
-$121M
Cap. Flow %
-50.38%
Top 10 Hldgs %
35.9%
Holding
637
New
293
Increased
61
Reduced
110
Closed
124

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$8.19M
2
TAK icon
Takeda Pharmaceutical
TAK
+$2.78M
3
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$1.61M
4
BP icon
BP
BP
+$1.57M
5
DG icon
Dollar General
DG
+$1.2M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$8.5M
2
MSFT icon
Microsoft
MSFT
+$8.02M
3
SDS icon
ProShares UltraShort S&P500
SDS
+$7.99M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$6.83M
5
AAPL icon
Apple
AAPL
+$5.75M

Sector Composition

Rank Sector Weight
1 Technology 29.63%
2 Communication Services 10.34%
3 Financials 10.2%
4 Healthcare 8.19%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INDB icon
376
Independent Bank
INDB
$3.99B
$3K ﹤0.01%
+45
New +$3.44K
KALV
377
DELISTED
KalVista Pharmaceuticals
KALV
$3K ﹤0.01%
+395
New +$2.95K
LCTX icon
378
Lineage Cell Therapeutics
LCTX
$269M
$3K ﹤0.01%
+2,237
New +$3.12K
NBIX icon
379
Neurocrine Biosciences
NBIX
$16.8B
$3K ﹤0.01%
+26
New +$2.71K
OCFC icon
380
OceanFirst Financial
OCFC
$1.68B
$3K ﹤0.01%
+161
New +$3.57K
ONB icon
381
Old National Bancorp
ONB
$10.2B
$3K ﹤0.01%
+211
New +$3.57K
OSBC icon
382
Old Second Bancorp
OSBC
$1.29B
$3K ﹤0.01%
+214
New +$3.41K
OTLK icon
383
Outlook Therapeutics
OTLK
$183M
$3K ﹤0.01%
+141
New +$3.15K
OZK icon
384
Bank OZK
OZK
$5.6B
$3K ﹤0.01%
89
-4,611
-98% -$194K
RNAC icon
385
Cartesian Therapeutics
RNAC
$229M
$3K ﹤0.01%
+66
New +$3.1K
SHBI icon
386
Shore Bancshares
SHBI
$819M
$3K ﹤0.01%
+211
New +$3.51K
TCBX icon
387
Third Coast Bancshares
TCBX
$729M
$3K ﹤0.01%
+194
New +$3.48K
TCRT icon
388
Alaunos Therapeutics
TCRT
$4.59M
$3K ﹤0.01%
+34
New +$3.24K
TEVA icon
389
Teva Pharmaceuticals
TEVA
$40.8B
$3K ﹤0.01%
+300
New +$2.97K
TRMK icon
390
Trustmark
TRMK
$2.76B
$3K ﹤0.01%
+121
New +$3.58K
VLY icon
391
Valley National Bancorp
VLY
$7.9B
$3K ﹤0.01%
+327
New +$3.62K
VYGR icon
392
Voyager Therapeutics
VYGR
$183M
$3K ﹤0.01%
+416
New +$3.31K
WABC icon
393
Westamerica Bancorp
WABC
$1.38B
$3K ﹤0.01%
+67
New +$3.6K
WAFD icon
394
WaFd
WAFD
$2.72B
$3K ﹤0.01%
+101
New +$3.42K
WBS icon
395
Webster Financial
WBS
$12.5B
$3K ﹤0.01%
77
-4,123
-98% -$198K
WST icon
396
West Pharmaceutical
WST
$24B
$3K ﹤0.01%
+8
New +$2.34K
YMAB
397
DELISTED
Y-mAbs Therapeutics
YMAB
$3K ﹤0.01%
+800
New +$3.27K
MCBC
398
DELISTED
Macatawa Bank Corp
MCBC
$3K ﹤0.01%
+299
New +$3.18K
LIAN
399
DELISTED
LianBio American Depositary Shares
LIAN
$3K ﹤0.01%
+1,678
New +$3.48K
ABCM
400
DELISTED
Abcam PLC
ABCM
$3K ﹤0.01%
+214
New +$3.19K
14 15
16
17 18

Similar funds

SCP
Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return
NCM
Newfoundland Capital Management Sao Paulo, Brazil $9.47M AUM 21.24% 1-Year Est. Return
PML
Prime Movers Lab Jackson, Wyoming $13.5M AUM 0% 1-Year Est. Return
MA
Macellum Advisors New York $7.23M AUM 23.78% 1-Year Est. Return
LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
PA
Pantechnicon Advisors London, United Kingdom $18.4M AUM 26.45% 1-Year Est. Return
OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
BV
Builders Vision Chicago, Illinois $2.34M AUM

Psagot Value Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, Psagot Value Holdings held 637 positions worth $240M, down 29% from $339M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Psagot Value Holdings withdrew a net $121M in Q1 2023, closing 124 positions and reducing 110 holdings. Its most notable exit was ProShares UltraShort S&P500, an estimated $7.99M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 23% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Psagot Value Holdings opened a new position in Takeda Pharmaceutical worth $2.83M.

  • Psagot Value Holdings's largest Q1 2023 buy was Takeda Pharmaceutical: 174,300 shares worth $2.83M.
  • Psagot Value Holdings added most to Vanguard S&P 500 ETF in Q1 2023, an estimated $8.19M increase.
  • Psagot Value Holdings's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $8.5M.
  • Psagot Value Holdings fully exited ProShares UltraShort S&P500 in Q1 2023, selling an estimated $7.99M.
  • Psagot Value Holdings's ten largest holdings make up 36% of its $240M portfolio in Q1 2023.
  • Psagot Value Holdings opened 293 new positions and closed 124 in Q1 2023.
  • Psagot Value Holdings's portfolio value fell 29% quarter-over-quarter to $240M.

Based on Psagot Value Holdings's 13F filing for Q1 2023, filed 20 Jun 2023.